Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure

GRI BIO, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 4 Kelly Leanne (CFO) has filed a Form 4 on GRI BIO, Inc.
Txns: Granted 83,333 options to buy @ $1.52, valued at $126.7k
08/14/2023 4 Szekeres David Leslie (Director) has filed a Form 4 on GRI BIO, Inc.
Txns: Granted 34,483 options to buy @ $2.9, valued at $100k
08/14/2023 4 SIMPSON CAMILLA V (Director) has filed a Form 4 on GRI BIO, Inc.
Txns: Granted 34,483 options to buy @ $2.9, valued at $100k
08/14/2023 4 Rongen Roelof (Director) has filed a Form 4 on GRI BIO, Inc.
Txns: Granted 34,483 options to buy @ $2.9, valued at $100k
08/14/2023 4 Baker David Charles (Director) has filed a Form 4 on GRI BIO, Inc.
Txns: Granted 34,483 options to buy @ $2.9, valued at $100k
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2022 4 Thorell Marella (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Disposed of 28,517 shares @ $0
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Ammer Richard (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 7,500 options to buy @ $0.51, valued at $3.8k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2022 4 Baker David Charles (CEO) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 61,000 options to buy @ $5.63, valued at $343.4k
03/01/2022 4 Kelly Leanne M. (CFO) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 50,000 options to buy @ $5.63, valued at $281.5k
06/04/2021 4 Kelly Leanne M. (CFO) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Bought 3,657 shares @ $4, valued at $14.6k
Bought 1,085 shares @ $4.05, valued at $4.4k
Bought 1,508 shares @ $4.08, valued at $6.2k
05/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Ammer Richard (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $3.66, valued at $54.9k
Granted 10,204 options to buy @ $3.66, valued at $37.3k
05/18/2021 4 Levi Ofir (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $3.66, valued at $54.9k
Granted 30,000 options to buy @ $3.66, valued at $109.8k
05/18/2021 4 Kelly Leanne M. (CFO) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 70,000 options to buy @ $3.66, valued at $256.2k
05/18/2021 4 Toren Penny (SVP, Regul Affairs & Prog Mgmt) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.66, valued at $91.5k
05/18/2021 4 Baker David Charles (CEO) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 100,000 options to buy @ $3.66, valued at $366k
02/12/2021 4 Ammer Richard (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Acquired 47,063 shares @ $6.4, valued at $301.2k
02/12/2021 4 SALMON Pharma GmbH (10% Owner) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Acquired 47,063 shares @ $6.4, valued at $301.2k
02/12/2021 4 Thorell Marella (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $8, valued at $120k
02/12/2021 4 Baker David Charles (CEO) has filed a Form 4 on Vallon Pharmaceuticals, Inc.
Txns: Acquired 7,843 shares @ $6.4, valued at $50.2k
Bought 1,000 shares @ $8, valued at $8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy